ABBY KOLTHOFF: Open Payments
NPI 1184056822 · WATERLOO, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,793 in 282 payments from 16 companies in 2025. Trend: 2023 $2,119 · 2024 $2,304 · 2025 $2,793
Food & beverage: $2,793
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 68 | $481 |
| ABBVIE INC. | 63 | $449 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 26 | $398 |
| Alkermes, Inc. | 30 | $322 |
| Otsuka America Pharmaceutical, Inc. | 19 | $218 |
| Janssen Pharmaceuticals, Inc | 34 | $214 |
| Axsome Therapeutics, Inc. | 11 | $201 |
| Teva Pharmaceuticals USA, Inc. | 16 | $135 |
| E.R. Squibb & Sons, L.L.C. | 5 | $117 |
| Supernus Pharmaceuticals, Inc. | 3 | $55 |
Products named: INGREZZA, VRAYLAR, CAPLYTA, ARISTADA, Auvelity, INVEGA SUSTENNA, REXULTI, AUSTEDO XR.
Industry payments across IA — which companies pay providers there.
